等待開盤 09-20 09:30:00 美东时间
+0.060
+1.42%
iTeos Therapeutics (NASDAQ:ITOS) announced Saturday that its experimental cancer doublet therapy developed with GSK (NYSE:GSK) outperformed the British drugmaker’s FDA-approved anti-PD-1 therapy dosta...
09-14 19:16
Roth MKM analysts updated their top ideas within their ADR universe. ADRs are U.S. dollar certificates that trade on American stock exchanges tracking the price of a foreign company’s domestic shares....
09-12 22:41
Mereo Biopharma Group PLC : Leerink Partners Raises Target Price to $8 From $6
06-20 11:27
Mereo Biopharma Group Plc (MREO) has shared an announcement. Mereo BioPharma Gr...
06-15 05:18
Ultragenyx Pharmaceutical (NASDAQ:RARE) announces the pricing of its underwritten public offering of 7,435,898 shares of its common stock at $39.00 per share, and pre-funded warrants offering to purch...
06-14 16:45
Baird initiated coverage of Mereo Biopharma (NASDAQ:MREO) with an outperform rating, citing its rare disease drugs setrusumab and alvelestat. Baird said it believes setrusumab represents a $750M+ reve...
06-14 04:48
Ultragenyx (NASDAQ:RARE) said it would submit a Biologics License Application to the U.S. FDA seeking accelerated approval of UX111, a gene therapy for Sanfilippo syndrome, a rare metabolic disease. T...
06-13 04:40
Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASD...
06-13 00:17
Mereo Biopharma Group Plc (MREO) has provided an announcement. Ultragenyx Pharm...
06-12 19:53
Mereo BioPharma (NASDAQ:MREO) traded higher premarket Wednesday after the company and its partner Ultragenyx Pharmaceutical (NASDAQ:RARE) announced 14-month data from a Phase 2 portion of an ongoing P...
06-12 19:00